Forte Biosciences, Inc. - FBRX

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 11.4% 1,425,785 View
Jan 29, 2026 SCHEDULE 13G/A Affinity Asset Advisors, LLC 6.7% 834,964 View
Jan 29, 2026 SCHEDULE 13G/A Michael Cho 6.7% 834,964 View
Jan 20, 2026 SCHEDULE 13G Point72 Asset Management, L.P. 6.3% 792,976 View
Jan 20, 2026 SCHEDULE 13G Point72 Capital Advisors, Inc. 6.3% 792,976 View
Jan 20, 2026 SCHEDULE 13G Steven A. Cohen 6.3% 792,976 View
Jan 09, 2026 SCHEDULE 13G/A Oliveira Steven Michael 2.4% 300,100 View
Jan 09, 2026 SCHEDULE 13G/A Nemean Asset Management, LLC 2.4% 300,100 View
Dec 23, 2025 SCHEDULE 13G Affinity Asset Advisors, LLC 6.9% 862,400 View
Dec 23, 2025 SCHEDULE 13G Affinity Healthcare Fund, LP 6.9% 862,400 View
Nov 14, 2025 SCHEDULE 13G/A Alger Associates, Inc. 13.1% 1,634,267 View
Nov 14, 2025 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND L P 0.3% 33,291 View
Nov 14, 2025 SCHEDULE 13G/A BVF I GP LLC 0.3% 33,291 View
Nov 14, 2025 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND II LP 0.2% 27,232 View
Nov 14, 2025 SCHEDULE 13G/A BVF II GP LLC 0.2% 27,232 View
Nov 14, 2025 SCHEDULE 13G/A Biotechnology Value Trading Fund OS LP 0.03% 3,468 View
Nov 14, 2025 SCHEDULE 13G/A BVF Partners OS Ltd. 0.03% 3,468 View
Nov 14, 2025 SCHEDULE 13G/A BVF GP HOLDINGS LLC 0.5% 60,523 View
Nov 14, 2025 SCHEDULE 13G/A BVF PARTNERS L P/IL 0.5% 65,350 View
Nov 14, 2025 SCHEDULE 13G/A BVF INC/IL 0.5% 65,350 View
Nov 14, 2025 SCHEDULE 13G/A LAMPERT MARK N 0.5% 65,350 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.